Skip to main content

Table 2 Clinicopathological characteristics of breast cancer patients in our collective

From: Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

   n (%)
Age <median 105(50%)
>median 105(50%)
Tumor grade 1 7(3,50%)
2 92(45,80%)
3 102(50,70%)
Tumor size pT1 88(46,60%)
pT2 78(41,30%)
pT3/4 23(12,20%)
Lymph node status pN0 119(57,50%)
pN1/2/3 88(42,50%)
Histological type ductal 75(58,10%)
lobular 16(12,40%)
other 38(29,40%)
ER/PR status negative 58(28,40%)
positive 146(71,60%)
HER2/neu 0 54(28,60%)
1 84(44,40%)
2 11(5,80%)
3 40(21,20%)